¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"high lateral myocardial infarction"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • lateral projection
    Ãø¸éÅõ¿µ(¹ý)
  • lateral pterygoid muscle
    °¡Âʳ¯°³±Ù, ¿ÜÃøÀ͵¹±Ù
  • lateral recumbent position
    ¿·´©¿îÀÚ¼¼, ½ÉÁîÀÚ¼¼, Ⱦ¿ÍÀ§
  • lateral sacral artery
    °¡ÂʾûÄ¡µ¿¸Æ, ¿Ü̵̿°ñµ¿¸Æ
  • lateral sinus
    °¡Âʱ¼, ¿ÜÃøµ¿
  • lateral spinothalamic tract
    °¡ÂÊô¼ö½Ã»ó·Î, ¿Ü̫̿¼ö½Ã»ó·Î
  • lateral sulcus
    °¡Âʰí¶û, ¿ÜÃø±¸
  • lateral sural cutaneous nerve
    °¡ÂÊÀåµýÁöÇǺνŰæ, ¿ÜÃøºñº¹ÇǽŰæ
  • lateral surface
    °¡Âʸé, ¿ÜÃø¸é, Ãø¸é
  • lateral venous lacuna
    °¡ÂÊÁ¤¸ÆÁÖ¸Ó´Ï
  • lateral ventricle
    °¡Âʳú½Ç, Ãø³ú½Ç
  • lateral view
    Ãø¸é¿µ»ó
  • primary lateral sclerosis
    ¿ø¹ß°¡ÂʰæÈ­Áõ, ¿ø¹ßÃø»è°æÈ­Áõ
  • retrograde lateral plantar artery flap
    ¿ªÇà°¡Âʹ߹ٴڵ¿¸ÆÇÇÆÇ, ¿ªÇà¿ÜÃøÁ·Àúµ¿¸ÆÇÇÆÇ
  • high altitude
    °íÁö-, °í¼Ò-
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • lateral beam spread
    °¡ÂÊÀ½¼ÓÈ®»ê
  • lateral bicipital sulcus
    °¡Âʵΰ¥·¡±Ù°í¶û
  • lateral brachial cutaneous nerve
    °¡ÂÊÀ§ÆÈÇǺνŰæ
  • lateral conjugate paralysis
    °¡ÂÊÁֽø¶ºñ
  • lateral corticospinal tract
    °¡ÂʰÑÁúô¼ö·Î, °¡ÂÊÇǶó¹Ô·Î
  • lateral decubitus position
    ¿·´©¿òÀÚ¼¼
  • lateral malleolar network
    °¡Âʺ¹»çµ¿¸Æ±×¹°
  • lateral nasal prominence
    °¡ÂÊÄÚÀ¶±â
  • lateral oblique position
    ¿·ºñ½ºµë´©¿òÀÚ¼¼
  • lateral orbital sulcus
    °¡ÂÊ´«È®°í¶û
  • lateral plantar nerve
    °¡Âʹ߹ٴڽŰæ
  • lateral plate mesoderm
    °¡ÂÊÆÇÁ߹迱
  • lateral recumbent position
    ¿·´©¿òÀÚ¼¼, Ãø¿ÍÀ§
  • lateral spinothalamic tract
    °¡ÂÊô¼ö½Ã»ó·Î
  • lateral sural cutaneous nerve
    °¡ÂÊÀåµýÁöÇǺνŰæ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • high altitude pulmonary edema
    °íÁöÆóºÎÁ¾.
  • high caloric diet
    °íÄ®·Î¸®½ÄÀÌ.
  • high cellular component
    °í¼¼Æ÷ ±¸¼º ¼ººÐ
  • high dizziness
    °í¼ÒÇö±âÁõ(Ë­ËÛ̴˻̡).
  • high dose rate
    °í¼±·®À²
  • high dose rate intraluminal radiotherapy
    °í¼±·®À² °ü³»¹æ»ç¼±Ä¡·á
  • high dose tolerance
    °ú·®°ü¿ë
  • high echo area
    °í ¿¡ÄÚ ±¸¿ª
  • high echo area
    °í (ÍÔ) ¿¡ÄÚ ¿ª (æ´)
  • high electron density
    °íÀüÀڹеµ(ÍÔï³í­ÚËöô).
  • high energy bond
    °í¿¡³ÊÁö °áÇÕ
  • high energy bond
    °í¿¡³ÊÁö°áÇÕ.
  • high energy phosphate bond
    °í¿¡³ÊÁöÀλ꿰°áÇÕ.
  • high energy radiation
    °í¿¡³ÊÁö¹æ»ç¼±
  • high fat diet
    °íÁö¹æ½ÄÀÌ.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • subendocardial infarction
    ½É³»¸·Çϰæ»öÁõ.
  • subendocardial infarction
    ½É³»¸·Çϰæ»öÁõ(ãýҮدù»ÌÛßáñø)
  • transmural infarction
    ÀüÃþ°æ»öÁõ
  • uterine infarction
    Àڱðæ»öÁõ(¡­ÌÛßáñø).
  • water shed infarction
    ºÐ¼ö°è¼º °æ»ö(ºÐ¼ö °è¼º°æ»ö).
  • water shed infarction
    ºÐ¼ö°è¼º °æ»ö(ÝÂ⩠ͣàõÌÛßá).
  • water shed infarction
    ºÐ¼ö°è¼º °æ»ö(ÝÂâ©Í£àõÌÛßá)
  • idiopathic myocardial hypertrophy
    Ư¹ß¼º ½É±Ùºñ´ëÁõ.
  • myocardiac,myocardial
    ½É±ÙÀÇ
  • myocardial
    ½É±Ù(ãýÐÉ)ÀÇ.
  • myocardial anoxia
    ½É±Ù¹«»ê¼ÒÁõ(ãýÐÉÙíß«áÈñø).
  • myocardial biospy
  • myocardial bridging
    ½É±Ù±³¶ô.
  • myocardial contractility
    ½É±Ù¼öÃ༺.
  • myocardial contractility
    ½É±Ù¼öÃà·Â
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • Lateral posterior choroidal branches
    °¡Âʵڸƶô°¡Áö
    [¿¾ ¿ë¾î] ¿ÜÃøÈĸƶôÃÑÁö
  • Posterior lateral nasal arteries
    °¡ÂʵÚÄÚµ¿¸Æ
    [¿¾ ¿ë¾î] ¿ÜÃøÈĺñµ¿¸Æ
  • Lateral occipitotemporal gyrus
    °¡ÂʵÚÅë¼ö°üÀÚÀ̶û
    [¿¾ ¿ë¾î] ¿ÜÃøÈĵÎÃøµÎȸ
  • Lateral occipital artery
    °¡ÂʵÚÅë¼ö¿±µ¿¸Æ
    [¿¾ ¿ë¾î] ¿ÜÃøÈĵÎÁö
  • Lateral dorsal nerve of great toe
    °¡ÂʵîÂʾöÁö¹ß°¡¶ô½Å°æ
    [¿¾ ¿ë¾î] ¹«Áö¿ÜÃø¹èÃøÁö½Å°æ
  • Lateral lymph nodes
    °¡Âʸ²ÇÁÀý
    [¿¾ ¿ë¾î] ¿ÜÃøÀÓÆÄÀý
  • Lateral mallear ligament
    °¡ÂʸÁÄ¡Àδë
    [¿¾ ¿ë¾î] ¿ÜÃøÃß°ñÀδë
  • Lateral surface
    °¡Âʸé
    [¿¾ ¿ë¾î] ¿ÜÃø¸é
  • Lateral surface
    °¡Âʸé
    [¿¾ ¿ë¾î] ¿ÜÃø¿¬
  • Lateral border
    °¡Âʸ𼭸®
    [¿¾ ¿ë¾î] ¿ÜÃø¿¬
  • Lateral margin
    °¡Âʸ𼭸®
    [¿¾ ¿ë¾î] ¿ÜÃø¿¬
  • Lateral marginal vein
    °¡Âʸ𼭸®Á¤¸Æ
    [¿¾ ¿ë¾î] ¿ÜÃø¿¬Á¤¸Æ
  • Lateral cervical lymph nodes
    °¡Âʸñ¸²ÇÁÀý
    [¿¾ ¿ë¾î] ¿ÜÃø°æÀÓÆÄÀý
  • Lateral talocalcaneal ligament
    °¡Âʸñ¸»¹ß²ÞÄ¡Àδë
    [¿¾ ¿ë¾î] ¿ÜÃø°ÅÁ¾Àδë
  • Lateral patellar retinaculum
    °¡Âʹ«¸­ÁöÁö¶ì
    [¿¾ ¿ë¾î] ¿ÜÃø½½°³Áö´ë
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • lateral thoracic artery
    ¿ÜÃøÈ䵿¸Æ
  • lateral tubercle
    ¿ÜÃø°áÀý
  • lateral ventricle
    Ãø³ú½Ç
  • lateral wall echo
    Ãøº®¿¡ÄÚ
  • prominence of lateral semicircular canal
    ¿ÜÃø¹Ý°í¸®°ñ°üÀ¶±â, ¿ÜÃø¹Ý±Ô°üÀ¶±â
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
MIRP myocardial infarction rehabilitation program
MIRU myocardial infarction research unit
NTMI nontransmural myocardial infarction
OMI office of medical investigator; old myocardial infarction
QMI Q-wave myocardial infarction
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
DMI Doppler Myocardial Imaging
MB Myocardial Bridge
MDF Myocardial Depressant Factor
MVO2 Myocardial O2 consumption
MBF Myocardial blood flow
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • high-frequency oscillation
    °íÁÖÆÄ Áøµ¿
  • high-power interaction
    °íÃâ·Â »óÈ£ ÀÛ¿ë
  • high-speed grinding
    °í¼Ó »èÁ¦
    ºü¸¥ ¼Óµµ·Î °¥¾Æ³»´Â °Í.
  • high-threshold class
    °í¿ªÄ¡±º
    ¿ªÄ¡ÀÇ Å©±â°¡ ³ôÀº Áý´Ü.
  • high-threshold mechanoreceptor
    °í¿ªÄ¡ ±â°è ¼ö¿ëü, °í¿ªÄ¡ ±â°è ¼ö¿ë±â
  • high-threshold neuron
    °í¿ªÄ¡ ´º¿ì·±
    ¹ÝÀÀÀ» ÀÏÀ¸Å°´Â µ¥ Å« ÀÚ±ØÀÌ ÇÊ¿äÇÑ ´º¿ì·±.
  • high-voltage stimulation
    °íÀü¾Ð ÀÚ±Ø
    ³ôÀº Àü¾ÐÀÇ Àü±â ÀÚ±Ø.
  • paramagnetic high susceptibility
    »óÀÚ¼º °íÀÚÈ­À²
  • super high field MR scanner
    ÃʰíÀÚÀå MR ½ºÄ³³Ê, Ãʰí ÀÚÀå Àڱ⠰ø¸í ½ºÄ³³Ê
  • tolerance to high altitude
    °í¼Ò ³»¼º
  • ultra high field MR scanner
    ÃʰíÀÚÀå Àڱ⠰ø¸í ½ºÄ³³Ê
  • ultra high speed handpiece
    Ãʰí¼Ó ÇÚµåÇǽº
    ÇÑ ½Ã°£¿¡ 100000-300000ȸÀüÀÇ ¼º´ÉÀ» °¡Áø ÇÚµåÇǽº.
  • amyotrophic lateral sclerosis
    ±ÙÀ§Ã༺ Ãø»è °æÈ­Áõ, ±ÙÀ§Ã༺ Ãø¹æ °æÈ­
    1. Ãßü·ÎÀÇ ´º·Ð ¹× ³ú°£°ú ô¼öÀÇ ¿îµ¿¼¼Æ÷ÀÇ ÁøÇ༺ÀÎ º¯¼ºÀ» Ư¡À¸·Î ÇÏ´Â ÁúȯÀ¸·Î¼­, »óÀ§ ¹× ÇÏÀ§ÀÇ ¿îµ¿½Å°æÀÇ °á¼ÕÀ» ÃÊ·¡ÇÑ´Ù. º¸Åë 2-3³â³»¿¡ »ç¸ÁÇÑ´Ù. 2. »óÀ§ 1Â÷ ¿îµ¿ ´º·Ð°ú ÇÏÀ§ 2Â÷ ¿îµ¿ ´º·ÐÀÌ ÇÔ²² ħ¹üµÇ´Â ¿øÀÎ ºÒ¸íÀÇ °èÅ뼺 ÁúȯÀ¸·Î 30-50¼¼ÀÇ ³²¼º¿¡°Ô ¸¹´Ù. Áö°¢Àå¾Ö´Â ¾ø´Ù. ´ë°³ ¼Õ ±ÙÀ°ÀÇ ±Ù·Â ÀúÇÏ¿Í À§ÃàÀÌ µÇ¸é¼­ Â÷Ãû ÁøÇàÇÏ¿© ÆÈ, ¾î±úÀÇ ±ÙÀ°¿¡ ¹ÌÄ£´Ù. ´õ ³ª¾Æ°¡ ÇÏÁöÀÇ ±ÙÀ°ÀÌ À§ÃàÇϰųª, ±¸À½, ¿¬Çϱٵµ ħ¹üµÇ¾î ±¸¸¶ºñ Áõ»óÀ» ³ªÅ¸³½´Ù. ½ÉºÎ¹Ý»ç´Â Åë»ó Ç×ÁøÇÏ°í ±ÙÀ°¿¡´Â ¼¶À¯¼º ¿¬ÃàÀ» º¸°Ô µÈ´Ù. ƯȿÀûÀÎ Ä¡·á¹ýÀº ¾ø°í ¿¹Èİ¡ ºÒ·®ÇÏ¸ç Æò±Õ 3³â, ´ëºÎºÐ 5³â À̳»¿¡ »ç¸ÁÇÑ´Ù.
  • central lateral
    Áß½É Ãø¹æ
  • chronic lateral pharyngitis
    ¸¸¼º ¿ÜÃø Àεο°, ¸¸¼º ¿ÜÃø¼º Àεο°
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
high altitude pulmonary oedema <physiology> The abnormal deposition of fluid into the lungs that occurs with exposure to lower barometric pressure and low oxygen.
(12 Jan 1998)
high altitude sickness A condition that results from the exposure to lower barometric pressure (lower oxygen concentration).
Synonym: acute mountain sickness.
(27 Sep 1997)
high blood cholesterol A condition where there is an above normal level of cholesterol in the bloodstream. A level of over 200 mg/dl is known to be a risk factor for heart disease. Less than 200 is desirable, 200 to 239 is considered borderline high, over 240 is considered high.
(27 Sep 1997)
high blood pressure <cardiology> Persistently high arterial blood pressure. Hypertension may have no known cause (essential or idiopathic hypertension) or be associated with other primary diseases (secondary hypertension).
This condition is considered a risk factor for the development of heart disease, peripheral vascular disease, stroke and kidney disease.
(29 Sep 1997)
high blood triglyceride <biochemistry> Elevation of triglycerides, a fatty substance found in the bloodstream. Normal triglyceride blood levels should be 10-150 milligrams per decilitre. Elevations of the triglyceride level (particularly in association with elevated cholesterol) have been correlated with the development of atherosclerosis, the underlying cause of heart disease and stroke.
Origin: Gr. Haima = blood
(27 Sep 1997)
high-bred Bred in high life; of pure blood.
Source: Websters Dictionary
(01 Mar 1998)
high-calorie diet A diet containing upward of 4,000 calories per day.
(05 Mar 2000)
high convex The segment of a sphere of short radius.
(05 Mar 2000)
high density lipoprotein <biochemistry> These lipoproteins acts to carry cholesterol in the bloodstream.
Raised high density lipoprotein levels have been correlated with a lower risk for heart disease. Less than 35 mg/dl is considered a positive risk factor for coronary artery disease, over 60 mg/dl is considered a negative risk factor (reduces your risk of heart disease).
Recent studies show a low high density lipoprotein level is the strongest predictor of cardiovascular death in women.
Acronym: HDL
(18 Nov 1997)
high dose tolerance The induction of tolerance by exposure to high doses of antigen.
(05 Mar 2000)
high-egg-passage vaccine Living Flury strain rabies virus at the 180th to 190th level egg passage (embryonate eggs), used for vaccination of cattle and cats, low-egg-passage (LEP) vaccine: at the 40th to 50th passage level, containing 103 to 104 mouse LD50; nonpathogenic in dogs but retains some pathogenicity for cattle and cats.
(05 Mar 2000)
high endothelial postcapillary venules Venule's in the lymph nodes, tonsils, and Peyer's patches that have a high-walled endothelium through which blood lymphocytes migrate into the lymphatic parenchyma.
(05 Mar 2000)
high enema An enema instilled high up into the colon.
Synonym: enteroclysis.
(05 Mar 2000)
high energy bond <chemistry> Chemical bonds that release more than 25kJ/mol on hydrolysis: their importance is that the energy can be used to transfer the hydrolysed residue to another compound. The risk in using the term is that students may think the bond itself is different in some way, whereas it is the compound that matters. Hydrolysis of creatine phosphate yields 42.7kJ/mol, of phosphoenolpyruvate, 53.2, ATP to ADP, 30.5: the latter is important because it shows that energetically the hydrolysis of creatine phosphate will suffice to reconstitute ATP, hence the use of creatine phosphate in muscle.
(18 Nov 1997)
high energy compounds Classically, a group of phosphoric esters whose hydrolysis takes place with a standard free energy change of -5 to -15 kcal/mol (or, -20 to -63 kJ/mol) (in contrast to -1 to -4 kcal/mol or, -4 to -17 kJ/mol) for simple phosphoric esters like glucose-6-phosphate or alpha-glycerophosphates), thus being capable of driving energy-consuming reactions in living cells or reconstituted cell-free systems; adenosine 5'-triphosphate, with respect to the beta-and gamma-phosphates, is the best known and is regarded as the immediate energy source for most metabolic syntheses. The general types are acid anhydrides, phosphoric esters of enols, phosphamic acid (R-NH-PO3H2) derivatives, acyl thioesters (e.g., of coenzyme A), sulfonium compound's (R3-S+), and aminoacyl esters of ribosyl moieties.
See: high energy phosphates.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • high jump
    ³ôÀ̶ٱâ
  • high life
    »ó·ù »çȸ(ÀÇ »ýȰ)
  • high liver
    »çÄ¡½º·¯¿î »ýȰÀ» ÇÏ´Â »ç¶÷;¹Ì½Ä°¡
  • high living
    ȣȭ½º·¯¿î »ýȰ 
  • high noon
    Çѳ·;Á¤¿À
  • high pillow
    °Å¹°;Áß¿ä Àι°
  • high pitch
    (³ëÁ¡ »óÀÎÀÇ)ÆÇ¸Å´ë
  • high place
    »ê²À´ë±âÀÇ ¿¹¹è Àå¼Ò;Áß¿äÇÑ ÁöÀ§;¿äÁ÷;°í°ü
  • high pockets
    Ű´Ù¸®
  • high point
    Áß´ëÇÑ ½ÃÁ¡;ÃÖ°íÀÇ ½Ã±â
  • high polymer
    °íºÐÀÚ(°Å´ëºÐÀÚ) ¹°Áú
  • high polymer chemistry
    °íºÐÀÚ(È­)ÇÐÀÇ;°­·ÂÇÑ;(±¤ÇÐ ±â±â°¡)¹èÀ²ÀÌ ³ôÀº;Á¤·ÂÀûÀÎ
  • high priest
    Á¦»çÀå;(¿¾ À¯´ë±³ÀÇ)´ëÁ¦»çÀå;°í½Â;(ÁÖÀÇ,¿îµ¿ÀÇ)ÁöµµÀÚ
  • high profile
    ¸íÈ®ÇÑ Åµµ(Á¤Ã¥);¼±¸íÇÑ ÀÔÀå
  • high relief
    =alto relievo
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
ÅëÇÕ°Ë»ö ¿Ï·á